Global Hormone Replacement Therapy (HRT) Market to Reach $40.5 Billion by 2027

ReportLinker

Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hormone Replacement Therapy (HRT) Industry" - https://www.reportlinker.com/p05961363/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global Hormone Replacement Therapy (HRT) Market to Reach $40.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$26.6 Billion in the year 2020, is projected to reach a revised size of US$40.5 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$22.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Human Growth Hormone Replacement Therapy segment is readjusted to a revised 7.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.8 Billion, While China is Forecast to Grow at 5.8% CAGR

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.1 Billion by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Testosterone Hormone Replacement Therapy Segment to Record 5.3% CAGR

In the global Testosterone Hormone Replacement Therapy segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.7 Billion in the year 2020 will reach a projected size of US$5.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.7 Billion by the year 2027.

Select Competitors (Total 47 Featured) -
Abbott Laboratories
Allergan Plc
Bayer AG
Novartis AG
Noven Pharmaceuticals Inc.
Novo Nordisk A/S
Pfizer Inc.
TherapeuticsMD Inc.


Read the full report: https://www.reportlinker.com/p05961363/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
An Introduction to Menopause and Hormone Replacement Therapy
Recent Market Activity
The HRT Controversy - An Insight
Newer Studies Challenge WHI Findings and Re-establish Safety of
HRT
Revised Recommendations of the NAMS and Endocrine Society
IMS Consensus Guidelines Paving Way for More Clarity of HRT
The Regional Divide
Increasing Number of Menopausal Women - A Major Market Driver
New Bioidentical Drugs Serve Unmet Market Needs
Generic Incursion in Hormone Replacement Therapy - List of
Drugs With and Without Approved Generic Versions
Intense Competition Marks the Global HRT Market
The Premarin Saga
Estrace Cream Drives Revenue Gains in Allergan?s HRT Portfolio
Hormone Replacement Therapy (HRT) - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Allergan Plc (Ireland)
Bayer AG (Germany)
Noven Pharmaceuticals, Inc. (USA)
Novartis AG(Switzerland)
Novo Nordisk A/S (Denmark)
Orion Pharma AB (Finland)
Pfizer, Inc. (USA)
TherapeuticsMD, Inc. (USA)

3. MARKET TRENDS & DRIVERS
Unmet Needs in Combination Therapies for HRT drive Research for
New Medicines
Topical Estrogens - More Safe and Effective
Transdermal HRT Products Present Exciting Opportunities
Phytoestrogens - The New Panacea for Menopausal Symptoms?
Diet Link to Menopause Symptoms Raises Interest
Impact of Soy and Other Phytoestrogens - A Reality Check
EstroG - A Successful Herbal Health Supplement in Alleviating
Menopausal Symptoms
The Growing Buzz around Bioidentical Drugs
Bio-identical Hormones - A Natural and Safe Substitute to
Synthetic HRT?
Pellet Therapy - A New Innovation Downsizes Conventional Issues
with Bioidentical HRT
Direct-to-Consumer Advertising for HRT - A Mixed Bag
Estriol: The Next Generation Estrogen Therapy?
What Makes Estriol Work?
Topical Estriol - More Promising in Safety
Estriol - Used More Commonly Outside the US
Entry of Generics Threatens Market Growth Prospects
Are Non-Hormonal Therapies A Threat to HRT?
Earlier Failures Induce Lethargy in Non-Hormonal Therapies

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Hormone Replacement Therapy
(HRT) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Estrogen Hormone Replacement Therapy by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Estrogen Hormone Replacement
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 6: World 15-Year Perspective for Estrogen Hormone
Replacement Therapy by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for Human
Growth Hormone Replacement Therapy by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Human Growth Hormone
Replacement Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Human Growth Hormone
Replacement Therapy by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Testosterone Hormone Replacement Therapy by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Testosterone Hormone
Replacement Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Testosterone Hormone
Replacement Therapy by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Thyroid Hormone Replacement Therapy by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Thyroid Hormone Replacement
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 15: World 15-Year Perspective for Thyroid Hormone
Replacement Therapy by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Menopause by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Menopause by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Menopause by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for Male
Hypogonadism by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Male Hypogonadism by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Male Hypogonadism by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Growth Hormone Deficiency by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Growth Hormone Deficiency
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Growth Hormone
Deficiency by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Hypothyroidism by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Hypothyroidism by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Hypothyroidism by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Other Type of Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Other Type of Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Other Type of Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027

Table 31: World Hormone Replacement Therapy (HRT) Market
Analysis of Annual Sales in US$ Million for Years 2012 through
2027

III. MARKET ANALYSIS

UNITED STATES
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 32: USA Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 33: USA Historic Review for Hormone Replacement Therapy
(HRT) by Product - Estrogen Hormone Replacement Therapy, Human
Growth Hormone Replacement Therapy, Testosterone Hormone
Replacement Therapy and Thyroid Hormone Replacement Therapy
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 34: USA 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 35: USA Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 36: USA Historic Review for Hormone Replacement Therapy
(HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth
Hormone Deficiency, Hypothyroidism and Other Type of Diseases
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 37: USA 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 39: Canada Historic Review for Hormone Replacement
Therapy (HRT) by Product - Estrogen Hormone Replacement
Therapy, Human Growth Hormone Replacement Therapy, Testosterone
Hormone Replacement Therapy and Thyroid Hormone Replacement
Therapy Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 40: Canada 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 41: Canada Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 42: Canada Historic Review for Hormone Replacement
Therapy (HRT) by Type of Disease - Menopause, Male
Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and
Other Type of Diseases Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 43: Canada 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

JAPAN
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 45: Japan Historic Review for Hormone Replacement Therapy
(HRT) by Product - Estrogen Hormone Replacement Therapy, Human
Growth Hormone Replacement Therapy, Testosterone Hormone
Replacement Therapy and Thyroid Hormone Replacement Therapy
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 46: Japan 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 47: Japan Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 48: Japan Historic Review for Hormone Replacement Therapy
(HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth
Hormone Deficiency, Hypothyroidism and Other Type of Diseases
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 49: Japan 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

CHINA
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 50: China Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 51: China Historic Review for Hormone Replacement Therapy
(HRT) by Product - Estrogen Hormone Replacement Therapy, Human
Growth Hormone Replacement Therapy, Testosterone Hormone
Replacement Therapy and Thyroid Hormone Replacement Therapy
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 52: China 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 53: China Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 54: China Historic Review for Hormone Replacement Therapy
(HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth
Hormone Deficiency, Hypothyroidism and Other Type of Diseases
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 55: China 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

EUROPE
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 56: Europe Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 57: Europe Historic Review for Hormone Replacement
Therapy (HRT) by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 58: Europe 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 59: Europe Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 60: Europe Historic Review for Hormone Replacement
Therapy (HRT) by Product - Estrogen Hormone Replacement
Therapy, Human Growth Hormone Replacement Therapy, Testosterone
Hormone Replacement Therapy and Thyroid Hormone Replacement
Therapy Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 61: Europe 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 62: Europe Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 63: Europe Historic Review for Hormone Replacement
Therapy (HRT) by Type of Disease - Menopause, Male
Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and
Other Type of Diseases Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 64: Europe 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

FRANCE
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 65: France Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 66: France Historic Review for Hormone Replacement
Therapy (HRT) by Product - Estrogen Hormone Replacement
Therapy, Human Growth Hormone Replacement Therapy, Testosterone
Hormone Replacement Therapy and Thyroid Hormone Replacement
Therapy Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 67: France 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 68: France Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 69: France Historic Review for Hormone Replacement
Therapy (HRT) by Type of Disease - Menopause, Male
Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and
Other Type of Diseases Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 70: France 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

GERMANY
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 71: Germany Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 72: Germany Historic Review for Hormone Replacement
Therapy (HRT) by Product - Estrogen Hormone Replacement
Therapy, Human Growth Hormone Replacement Therapy, Testosterone
Hormone Replacement Therapy and Thyroid Hormone Replacement
Therapy Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 73: Germany 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 74: Germany Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 75: Germany Historic Review for Hormone Replacement
Therapy (HRT) by Type of Disease - Menopause, Male
Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and
Other Type of Diseases Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 76: Germany 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

ITALY
Table 77: Italy Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 78: Italy Historic Review for Hormone Replacement Therapy
(HRT) by Product - Estrogen Hormone Replacement Therapy, Human
Growth Hormone Replacement Therapy, Testosterone Hormone
Replacement Therapy and Thyroid Hormone Replacement Therapy
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 79: Italy 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 80: Italy Recent Past, Current & Future Analysis for
Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 81: Italy Historic Review for Hormone Replacement Therapy
(HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth
Hormone Deficiency, Hypothyroidism and Other Type of Diseases
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 82: Italy 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

UNITED KINGDOM
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 83: UK Recent Past, Current & Future Analysis for Hormone
Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 84: UK Historic Review for Hormone Replacement Therapy
(HRT) by Product - Estrogen Hormone Replacement Therapy, Human
Growth Hormone Replacement Therapy, Testosterone Hormone
Replacement Therapy and Thyroid Hormone Replacement Therapy
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 85: UK 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Product - Percentage Breakdown of Value Sales
for Estrogen Hormone Replacement Therapy, Human Growth Hormone
Replacement Therapy, Testosterone Hormone Replacement Therapy
and Thyroid Hormone Replacement Therapy for the Years 2012,
2021 & 2027

Table 86: UK Recent Past, Current & Future Analysis for Hormone
Replacement Therapy (HRT) by Type of Disease - Menopause, Male
Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and
Other Type of Diseases - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 87: UK Historic Review for Hormone Replacement Therapy
(HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth
Hormone Deficiency, Hypothyroidism and Other Type of Diseases
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 88: UK 15-Year Perspective for Hormone Replacement
Therapy (HRT) by Type of Disease - Percentage Breakdown of
Value Sales for Menopause, Male Hypogonadism, Growth Hormone
Deficiency, Hypothyroidism and Other Type of Diseases for the
Years 2012, 2021 & 2027

REST OF EUROPE
Table 89: Rest of Europe Recent Past, Current & Future Analysis
for Hormone Replacement Therapy (HRT) by Product - Estrogen
Hormone Replacement Therapy, Human Growth Hormone Replacement
Therapy, Testosterone Hormone Replacement Therapy and Thyroid
Hormone Replacement Therapy - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 90: Rest of Europe Historic Review for Hormone
Replacement Therapy (HRT) by Product - Estrogen Hormone
Replacement Therapy, Human Growth Hormone Replacement Therapy,
Testosterone Hormone Replacement Therapy and Thyroid Hormone
Replacement Therapy Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 91: Rest of Europe 15-Year Perspective for Hormone
Replacement Therapy (HRT) by Product - Percentage Breakdown of
Value Sales for Estrogen Hormone Replacement Therapy, Human
Growth Hormone Replacement Therapy, Testosterone Hormone
Replacement Therapy and Thyroid Hormone Replacement Therapy for
the Years 2012, 2021 & 2027

Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Hormone Replacement Therapy (HRT) by Type of Disease -
Menopause, Male Hypogonadism, Growth Hormone Deficiency,
Hypothyroidism and Other Type of Diseases - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 93: Rest of Europe Historic Review for Hormone
Replacement Therapy (HRT) by Type of Disease - Menopause, Male
Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and
Other Type of Diseases Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 94: Rest of Europe 15-Year Perspective for Hormone
Replacement Therapy (HRT) by Type of Disease - Percentage
Breakdown of Value Sales for Menopause, Male Hypogonadism,
Growth Hormone Deficiency, Hypothyroidism and Other Type of
Diseases for the Years 2012, 2021 & 2027

ASIA-PACIFIC
Hormone Replacement Therapy (HRT) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2022 (E)
Table 95: Asia-Pacific Recent Past, Current & Future Analysis
for Hormone Replacement Therapy (HRT) by Product - Estrogen
Hormone Replacement Therapy, Human Growth Hormone Replacement
Therapy, Testosterone Hormone Replacement Therapy and Thyroid
Hormone Replacement Therapy - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 96: Asia-Pacific Historic Review for Hormone Replacement
Therapy (HRT) by Product - Estrogen Hormone Replacement
Therapy, Human Growth Hormone Replacement Therapy, Testosterone
Hormone Replacement Therapy and Thyroid Hormone Replacement

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05961363/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001